Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Q1 Sales & Earnings: An Opportunity For Clarity In An Uncertain Time

Apr 13 2020

• By Jessica Merrill

First quarter earnings may offer some clarity on business dynamics • Source: Shutterstock

Related Content

Stunning Start For Vertex Cystic Fibrosis Triple Combo

Jan 31 2020

Sage Makes Deep Cuts, Axing 53% Of The Workforce, As It Reins In Zulresso

Apr 08 2020

BMS Gets US Approval Of Ozanimod For Relapsing MS, But Launch Delayed

Mar 26 2020

Coronavirus Update: Vertex, Pfizer And Others Disclose Trial Disruptions, Viatris Merger Delayed

Mar 30 2020

In A Volatile Time, Pharma Reassures Business Remains Steady

Mar 09 2020

Pfizer Vyndaqel Launch Surprises With An Early Burst Out Of The Gate

Oct 29 2019

Bad For Pharma: Sales Reps And Patients Are Staying Home

Mar 18 2020

Related Companies

Johnson & Johnson

Gilead Sciences, Inc.

Biogen, Inc.

Sage Therapeutics, Inc.

Bristol Myers Squibb Company

Novartis AG

AbbVie Inc.

AstraZeneca PLC

Daiichi Sankyo Co., Ltd.

BioMarin Pharmaceutical Inc.

Vertex Pharmaceuticals Incorporated

Pfizer Inc.

Viatris Inc.

Viatris Inc.

Eli Lilly and Company

Additional Topics

Coronavirus COVID-19 Sales & Earnings Launches Leadership Business Strategies Commercial BioPharmaceutical

More from COVID-19

More from Scrip

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.